July 26, 2006
Proposed amendments to the law, if passed, will force the Kenyan Government to purchase patented drugs and restrict access to generics.
Treatment for endemic conditions such as Aids and for infectious diseases including malaria and tuberculosis are likely to soar to three to ten times current prices. Read the rest of this entry »
Leave a Comment » |
News, Patents, Teva, pharmaceuticals and Biotechnology |
Permalink
Posted by Dr Michael Factor
July 20, 2006
In a blog-entry published back in February 2, 2006, now deleted, I reported a high profile labor dispute, specifically that Patent Attorney Itzhak Rachailovich (now associated with Factor – Patent Attorneys) was suing his former employer Dr.Shlomo Cohen and Dr. Shlomo Cohen & Partners for redundancy benefits, and briefly described the main claims of both sides as reported in the papers.
In that blog-entry I reported that Itzhak Rachailovitch was “formerly head of the intellectual property department at Dr. Shlomo Cohen & Co.”. This was a typographical error. During his employment at Dr. Shlomo Cohen & Partners, Mr. Rachailovich’s responsibilities there were confined to Patent work only. I retract the original statement and apologize to Dr. Shlomo Cohen for any damage to his reputation that the erroneous statement regarding the scope of Mr. Rachailovich’s responsibilities may have caused him and his firm.
Leave a Comment » |
Israel Related, News, Patents, Uncategorized |
Permalink
Posted by Dr Michael Factor
July 4, 2006
On July 1, 2006, the Israel Patent Office fees underwent their biannual adjustment in accordance with the cost of living.
All fees have gone up around 1%. The basic fee for Read the rest of this entry »
Leave a Comment » |
Israel IP, Israel Patent, Israel Patent Office Rulings, Israel Related, Israel Trademark, News, Opinion, Patents, Uncategorized |
Permalink
Posted by Dr Michael Factor
July 2, 2006
Three drugs: Fosamax, Evista and Actonel dominate the osteoporosis treatment market, and a fourth drug, Boniva, recently became available.
Teva Pharmaceutical successfully fought Read the rest of this entry »
Leave a Comment » |
Israel Related, News, Patents, Teva, US Patent Office, pharmaceuticals and Biotechnology |
Permalink
Posted by Dr Michael Factor
July 2, 2006
Teva has now received final approval to market a generic version of Pfizer’s Antidepressant, Zoloft®. The drug has 3 billion dollars of sales annually, and has been around for 14 years. Teva’s version will be available within weeks.
Zoloft® (sertraline HCl) is a selective serotonin Read the rest of this entry »
Leave a Comment » |
Israel Related, News, Patents, Teva, pharmaceuticals and Biotechnology |
Permalink
Posted by Dr Michael Factor
July 2, 2006
In a recent ruling, on 25 June 2006, Dr. Meir Noam, the Israel Commissioner of Patents has upheld a decision of the Trademark Department not to allow registration of the marks Lencor and Lengo for domestic appliances. Read the rest of this entry »
Leave a Comment » |
Israel IP, Israel Patent Office Rulings, Israel Related, Israel Trademark, News, Opinion, trademarks |
Permalink
Posted by Dr Michael Factor